PAR-5 is a PARty Hub in the Germline: Multitask Proteins in Development and Disease

Overview

Journal Worm

Date 2013 Sep 24

PMID 24058859

Citations 1

Authors

David Aristizabal-Corrales

Simo Schwartz Jr

Julian Ceron

Affiliations

Soon will be listed here.

Abstract

As our understanding of how molecular machineries work expands, an increasing number of proteins that appear as regulators of different processes have been identified. These proteins are hubs within and among functional networks. The 14-3-3 protein family is involved in multiple cellular pathways and, therefore, influences signaling in several disease processes, from neurobiological disorders to cancer. As a consequence, 14-3-3 proteins are currently being investigated as therapeutic targets. Moreover, 14-3-3 protein levels have been associated with resistance to chemotherapies. There are seven 14-3-3 genes in humans, while Caenorhabditis elegans only possesses two, namely par-5 and ftt-2. Among the C. elegans scientific community, par-5 is mainly recognized as one of the par genes that is essential for the asymmetric first cell division in the embryo. However, a recent study from our laboratory describes roles of par-5 in germ cell proliferation and in the cellular response to DNA damage induced by genotoxic agents. In this review, we explore the broad functionality of 14-3-3 proteins in C. elegans and comment on the potential use of worms for launching a drugs/modifiers discovery platform for the therapeutic regulation of 14-3-3 function in cancer.

Citing Articles

The 14-3-3 protein PAR-5 regulates the asymmetric localization of the LET-99 spindle positioning protein.

Wu J, Espiritu E, Rose L Dev Biol. 2016; 412(2):288-297.

PMID: 26921457 PMC: 4829500. DOI: 10.1016/j.ydbio.2016.02.020.

References

Neal C, Yu D . 14-3-3ζ as a prognostic marker and therapeutic target for cancer. Expert Opin Ther Targets. 2010; 14(12):1343-54. PMC: 3017465. DOI: 10.1517/14728222.2010.531011. View

Morton D, Shakes D, Nugent S, Dichoso D, Wang W, Golden A . The Caenorhabditis elegans par-5 gene encodes a 14-3-3 protein required for cellular asymmetry in the early embryo. Dev Biol. 2002; 241(1):47-58. DOI: 10.1006/dbio.2001.0489. View

Zhuang J, Hunter C . Tissue specificity of Caenorhabditis elegans enhanced RNA interference mutants. Genetics. 2011; 188(1):235-7. PMC: 3120140. DOI: 10.1534/genetics.111.127209. View

Tzivion G, Gupta V, Kaplun L, Balan V . 14-3-3 proteins as potential oncogenes. Semin Cancer Biol. 2006; 16(3):203-13. DOI: 10.1016/j.semcancer.2006.03.004. View

Ottmann C, Weyand M, Sassa T, Inoue T, Kato N, Wittinghofer A . A structural rationale for selective stabilization of anti-tumor interactions of 14-3-3 proteins by cotylenin A. J Mol Biol. 2009; 386(4):913-9. DOI: 10.1016/j.jmb.2009.01.005. View

Zhao J, Meyerkord C, Du Y, Khuri F, Fu H . 14-3-3 proteins as potential therapeutic targets. Semin Cell Dev Biol. 2011; 22(7):705-12. PMC: 3207012. DOI: 10.1016/j.semcdb.2011.09.012. View

She Q, Solit D, Ye Q, OReilly K, Lobo J, Rosen N . The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells. Cancer Cell. 2005; 8(4):287-97. PMC: 3203692. DOI: 10.1016/j.ccr.2005.09.006. View

Lacoste C, Barthaux V, Iborra C, Seagar M, Erard-Garcia M . MAU-8 is a Phosducin-like Protein required for G protein signaling in C. elegans. Dev Biol. 2006; 294(1):181-91. DOI: 10.1016/j.ydbio.2006.02.039. View

Agarwal S, Deane C, Porter M, Jones N . Revisiting date and party hubs: novel approaches to role assignment in protein interaction networks. PLoS Comput Biol. 2010; 6(6):e1000817. PMC: 2887459. DOI: 10.1371/journal.pcbi.1000817. View

10.

Vazquez A, Grochola L, Bond E, Levine A, Taubert H, Muller T . Chemosensitivity profiles identify polymorphisms in the p53 network genes 14-3-3tau and CD44 that affect sarcoma incidence and survival. Cancer Res. 2009; 70(1):172-80. DOI: 10.1158/0008-5472.CAN-09-2218. View

11.

Popovici C, Berda Y, Conchonaud F, Harbis A, Birnbaum D, Roubin R . Direct and heterologous approaches to identify the LET-756/FGF interactome. BMC Genomics. 2006; 7:105. PMC: 1513213. DOI: 10.1186/1471-2164-7-105. View

12.

Zhao J, Du Y, Horton J, Upadhyay A, Lou B, Bai Y . Discovery and structural characterization of a small molecule 14-3-3 protein-protein interaction inhibitor. Proc Natl Acad Sci U S A. 2011; 108(39):16212-6. PMC: 3182712. DOI: 10.1073/pnas.1100012108. View

13.

Li Y, Zou L, Li Q, Haibe-Kains B, Tian R, Li Y . Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer. Nat Med. 2010; 16(2):214-8. PMC: 2826790. DOI: 10.1038/nm.2090. View

14.

Gardino A, Yaffe M . 14-3-3 proteins as signaling integration points for cell cycle control and apoptosis. Semin Cell Dev Biol. 2011; 22(7):688-95. PMC: 3507455. DOI: 10.1016/j.semcdb.2011.09.008. View

15.

Neupane D, Korc M . 14-3-3sigma Modulates pancreatic cancer cell survival and invasiveness. Clin Cancer Res. 2008; 14(23):7614-23. PMC: 3142357. DOI: 10.1158/1078-0432.CCR-08-1366. View

16.

Wang B, Yang H, Liu Y, Jelinek T, Zhang L, Ruoslahti E . Isolation of high-affinity peptide antagonists of 14-3-3 proteins by phage display. Biochemistry. 1999; 38(38):12499-504. DOI: 10.1021/bi991353h. View

17.

Li J, Tewari M, Vidal M, Lee S . The 14-3-3 protein FTT-2 regulates DAF-16 in Caenorhabditis elegans. Dev Biol. 2006; 301(1):82-91. PMC: 1963419. DOI: 10.1016/j.ydbio.2006.10.013. View

18.

Li Z, Liu J, Zhang J . 14-3-3sigma, the double-edged sword of human cancers. Am J Transl Res. 2009; 1(4):326-40. PMC: 2780041. View

19.

Calixto A, Chelur D, Topalidou I, Chen X, Chalfie M . Enhanced neuronal RNAi in C. elegans using SID-1. Nat Methods. 2010; 7(7):554-9. PMC: 2894993. DOI: 10.1038/nmeth.1463. View

20.

Winter J, Hopfner S, Korn K, Farnung B, Bradshaw C, Marsico G . Caenorhabditis elegans screen reveals role of PAR-5 in RAB-11-recycling endosome positioning and apicobasal cell polarity. Nat Cell Biol. 2012; 14(7):666-76. DOI: 10.1038/ncb2508. View